Axcelis Technologies, Inc. (ACLS) Misses Q1 EPS by 1c
Tweet
Share
E-mailGet Alerts ACLS Hot Sheet
Price: $115.56 --0%
Revenue Growth %: +0.5%
Financial Fact:
Service: 6.35M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +0.5%
Financial Fact:
Service: 6.35M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Axcelis Technologies, Inc. (NASDAQ: ACLS) reported Q1 EPS of ($0.09), $0.01 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $55 million versus the consensus estimate of $63.48 million.
For earnings history and earnings-related data on Axcelis Technologies, Inc. (ACLS) click here.
For earnings history and earnings-related data on Axcelis Technologies, Inc. (ACLS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Macy's (M) Tops Q2 EPS by 28c, Beats on Revenue; Offers FY Guidance
- Cannabis Strategic Ventures signs LOI to acquire ad-tech firm Adport
- H.C. Wainwright Reiterates Neutral Rating on BioMarin Pharmaceutical Inc. (BMRN)
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
